Lixte Biotechnology Announces Merger Agreement to Acquire NOMAD Transportable Power Systems

On June 11, 2026, Lixte Biotechnology Holdings, Inc. entered into a definitive Merger Agreement to acquire NOMAD Transportable Power Systems, Inc. through a reverse merger. Upon closing, NOMAD will become a wholly-owned subsidiary of Lixte, and Lixte will change its corporate name to "NOMAD POWER SOLUTIONS, INC." The merger consideration consists of up to 3,000,000 shares of common stock and 50,500 shares of newly designated Series D Convertible Preferred Stock. The Series D shares have an original issue price of $1,000 per share and are convertible into 50,500,000 shares of common stock at $1.00 per share, subject to stockholder approval. Lixte must hold a stockholder meeting within 60 days of closing to approve this conversion. A critical closing condition is the "Closing Cash Condition," requiring Lixte to have at least $16.5 million in unrestricted cash. To satisfy this, Lixte intends to conduct private placement equity financings. The agreement also includes the appointment of John Travaglini as CEO of the subsidiary and board representation for NOMAD. The deal may be terminated if not consummated within 120 days.